Mingfang Zhao

2.0k total citations
63 papers, 1.2k citations indexed

About

Mingfang Zhao is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Mingfang Zhao has authored 63 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 24 papers in Oncology and 15 papers in Molecular Biology. Recurrent topics in Mingfang Zhao's work include Lung Cancer Treatments and Mutations (11 papers), Radiomics and Machine Learning in Medical Imaging (11 papers) and Gastric Cancer Management and Outcomes (7 papers). Mingfang Zhao is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Radiomics and Machine Learning in Medical Imaging (11 papers) and Gastric Cancer Management and Outcomes (7 papers). Mingfang Zhao collaborates with scholars based in China, United States and United Kingdom. Mingfang Zhao's co-authors include Heming Li, Xiujuan Qu, Jinglei Qu, Alan Neaigus, Ruoyu Wang, Samuel R. Friedman, V. Anna Gyarmathy, Zhi Li, Yuee Teng and Bo Jin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Mingfang Zhao

60 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingfang Zhao China 22 382 347 328 183 180 63 1.2k
Chao Zhou China 19 355 0.9× 486 1.4× 490 1.5× 260 1.4× 211 1.2× 90 1.6k
Hao Chen China 21 365 1.0× 281 0.8× 405 1.2× 112 0.6× 270 1.5× 120 1.4k
Panwen Tian China 20 737 1.9× 403 1.2× 265 0.8× 186 1.0× 110 0.6× 96 1.2k
Minmin Li China 19 193 0.5× 216 0.6× 236 0.7× 157 0.9× 236 1.3× 65 961
Yaping Xu China 19 495 1.3× 411 1.2× 317 1.0× 143 0.8× 110 0.6× 63 1.1k
Hua Jiang China 20 173 0.5× 393 1.1× 562 1.7× 172 0.9× 152 0.8× 112 1.6k
Bin Xu China 22 465 1.2× 613 1.8× 728 2.2× 129 0.7× 143 0.8× 97 1.9k
Lorraine Pelosof United States 16 299 0.8× 694 2.0× 371 1.1× 57 0.3× 300 1.7× 35 1.8k

Countries citing papers authored by Mingfang Zhao

Since Specialization
Citations

This map shows the geographic impact of Mingfang Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingfang Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingfang Zhao more than expected).

Fields of papers citing papers by Mingfang Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingfang Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingfang Zhao. The network helps show where Mingfang Zhao may publish in the future.

Co-authorship network of co-authors of Mingfang Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Mingfang Zhao. A scholar is included among the top collaborators of Mingfang Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingfang Zhao. Mingfang Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yining, Xin Li, Yuchong Zhang, et al.. (2025). The 3PM transformation potential of minimal residual disease in solid tumor management: a bibliometric analysis and review. The EPMA Journal. 16(3). 669–688.
2.
Xiao, Hong, Jingqi Sun, Qi Guan, et al.. (2025). Evolution of TROP2: Biological insights and clinical applications. European Journal of Medicinal Chemistry. 296. 117863–117863. 4 indexed citations
3.
Bai, Ming, Peng Xu, Rong Cheng, et al.. (2025). ROS-ATM-CHK2 axis stabilizes HIF-1α and promotes tumor angiogenesis in hypoxic microenvironment. Oncogene. 44(21). 1609–1619. 2 indexed citations
4.
5.
Li, Heming, Lu Xu, Tao Han, et al.. (2024). Exploring new frontiers: cell surface vimentin as an emerging marker for circulating tumor cells and a promising therapeutic target in advanced gastric Cancer. Journal of Experimental & Clinical Cancer Research. 43(1). 129–129. 11 indexed citations
6.
Qi, Lisha, Xiaoli Li, Yong Yang, et al.. (2024). Accuracy of machine learning in the preoperative identification of ovarian borderline tumors: a meta-analysis. Clinical Radiology. 79(7). 501–514. 1 indexed citations
7.
Li, Xin, et al.. (2024). Immune checkpoint inhibitors rechallenge in non-small cell lung cancer: Current evidence and future directions. Cancer Letters. 604. 217241–217241. 21 indexed citations
8.
Xu, Lu, Sha Shi, Xin Li, et al.. (2024). Intercellular adhesion molecule-1 (ICAM-1): From molecular functions to clinical applications in cancer investigation. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1879(6). 189187–189187. 13 indexed citations
9.
Zhao, Mingfang, et al.. (2024). Study on quality control methods and pharmacodynamic material basis of different specifications of Corydalis Rhizoma produced in Zhejiang Province. Journal of Ethnopharmacology. 332. 118375–118375. 1 indexed citations
10.
Zhao, Mingfang, et al.. (2024). [Neurodevelopment and cerebral blood flow in children aged 2-6 years with autism spectrum disorder].. PubMed. 26(6). 599–604. 2 indexed citations
11.
Zhang, Yuchong, Hui Qu, Ying Wu, et al.. (2023). PB-LNet: a model for predicting pathological subtypes of pulmonary nodules on CT images. BMC Cancer. 23(1). 936–936. 9 indexed citations
12.
Lv, Yue, Rui Tang, Mingfang Zhao, et al.. (2023). Rapid quality identification of the whole wine-steamed process of Polygonati Rhizome by chromaticity and near-infrared spectroscopy. Infrared Physics & Technology. 131. 104668–104668. 5 indexed citations
13.
Xu, Lu, et al.. (2022). SMARCA4: Current status and future perspectives in non-small-cell lung cancer. Cancer Letters. 554. 216022–216022. 58 indexed citations
14.
Han, Tao, et al.. (2022). Identification of the Mechanism of Matrine Combined with Glycyrrhizin for Hepatocellular Carcinoma Treatment through Network Pharmacology and Bioinformatics Analysis. Oxidative Medicine and Cellular Longevity. 2022(1). 2663758–2663758. 9 indexed citations
15.
16.
Zhao, Mingfang & Tao Han. (2021). Camrelizumab monotherapy or in combination with apatinib for PD-L1-positive advanced pulmonary sarcomatoid carcinoma: A multicenter, open-label, single-arm, phase II study.. Journal of Clinical Oncology. 39(15_suppl). TPS9130–TPS9130. 1 indexed citations
17.
Zhao, Mingfang, et al.. (2020). [Advances and Challenges of Local Thermal Ablation in Non-small Cell Lung Cancer].. SHILAP Revista de lepidopterología. 23(2). 111–117. 5 indexed citations
18.
Zhang, Zhe, Yishan Chen, Rui Ding, et al.. (2017). Significant benefit of Nivolumab treating PD-L1 positive metastatic pulmonary carcinosarcoma: a case report and literature review. Oncotarget. 8(56). 96453–96459. 12 indexed citations
19.
Qu, Jinglei, Mingfang Zhao, Ye Zhang, et al.. (2011). Interferon-α sensitizes human gastric cancer cells to TRAIL-induced apoptosis via activation of the c-CBL-dependent MAPK/ERK pathway. Cancer Biology & Therapy. 12(6). 494–502. 29 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chao Zhou Breakdown of academic impact, for papers by Hao Chen Breakdown of academic impact, for papers by Panwen Tian Breakdown of academic impact, for papers by Minmin Li Breakdown of academic impact, for papers by Yaping Xu Breakdown of academic impact, for papers by Hua Jiang Breakdown of academic impact, for papers by Bin Xu Breakdown of academic impact, for papers by Lorraine Pelosof
Rankless by CCL
2026